Intracellular and extracellular mechanisms of Gal-3 supporting the survival and proliferation of CLL cells indicate that this protein is also an important component of the TME and may be a possible target for therapy [10]. The gene discussed is LGALS3; the disease is B-cell chronic lymphocytic leukemia.